Clinical Trials Browser

Phase 3 × Olanzapine × Gynecologic × Clear all

NCT04503668 2025-06-18

Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients

Phase 3 Terminated

62 enrolled 16 charts

Gynecologic Cancer